Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Yuanhong Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7524-4697; OpenAlex author ID A5103051382. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: 1 paper · 2016: 5 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 3 papers · 2022: 1 paper

Papers 12

  1. ITGBL1 transcriptionally inhibited by JDP2 promotes the development of pancreatic cancer through the TGF-beta/Smad pathway. Last author DOI 10.1590/1414-431x2022e11989↗
  2. Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer. First author DOI 10.1002/cam4.3819↗
  3. Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression. Co-author DOI 10.1038/s41419-021-03938-8↗
  4. Regulation of ABCG2 expression by Wnt5a through FZD7 in human pancreatic cancer cells. Co-author DOI 10.3892/mmr.2020.11690↗
  5. siRNA-Mediated SBF2 Silencing May Inhibit Pancreatic Cancer Cells via Attenuation of the TGF-β Signaling Pathway. Co-author DOI 10.1177/1533034615580724↗
  6. Screening for genes and subnetworks associated with pancreatic cancer based on the gene expression profile. Co-author DOI 10.3892/mmr.2016.5007↗
  7. Gene expression profile analysis of pancreatic cancer based on microarray data. Co-author DOI 10.3892/mmr.2016.5021↗
  8. Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses. Co-author DOI 10.3892/ol.2015.4042↗
  9. Identification of disease-associated pathways in pancreatic cancer by integrating genome-wide association study and gene expression data. Co-author DOI 10.3892/ol.2016.4637↗
  10. microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression. Last author DOI 10.3978/j.issn.1000-9604.2015.04.06↗
  11. The effect of JDP2 and ATF2 on the epithelial-mesenchymal transition of human pancreatic cancer cell lines. Co-author DOI 10.1007/s12253-011-9476-6↗
  12. JDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cells. Last author DOI 10.1007/s13277-012-0404-5↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhongbo Zhang · 4 shared papers, 2016–2022 · strength 0.68
  2. Jin Long · 7 shared papers, 2012–2016 · strength 0.47
  3. Chenghai Zhao · 2 shared papers, 2021 · strength 0.41
  4. Xingda Wu · 4 shared papers, 2016 · strength 0.30
  5. Kejian Guo · 4 shared papers, 2012–2021 · strength 0.29
  6. Zhe Liu · 4 shared papers, 2015–2016 · strength 0.28
  7. Chunlin Ge · 3 shared papers, 2016 · strength 0.23
  8. Zhe Liu · 2 shared papers, 2016–2021 · strength 0.22
  9. Chunlin Ge · 3 shared papers, 2015–2016 · strength 0.21
  10. Tiancong Du · 1 shared paper, 2022 · strength 0.19
  11. Gang Ma · 1 shared paper, 2021 · strength 0.15
  12. Shaowei Song · 1 shared paper, 2021 · strength 0.15
  13. Ruixia Du · 2 shared papers, 2012–2015 · strength 0.09
  14. Zhe Liu · 2 shared papers, 2012 · strength 0.09
  15. Zhe Liu · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.